HMG-CoA合成酶抑制剂在脑缺血中的神经保护作用
出处
《医学综述》
2003年第9期554-556,共3页
Medical Recapitulate
参考文献19
-
1Blauw GJ, Laggay AM, Smelt AH, et al. Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-eontroned, double-blind trials with HMG-CoA reductase inhibitors [J]. Stroke,1997,28(2):946-950.
-
2Crouse JR III, Byington PIP, Hoen HM, et al. Reductaae inhibitor monotherapy and stroke prevention[J]. Arch Intern Med, 1997,157(5):1305-1310.
-
3Hebert PR, Gaziano JM, Chan KS, et al. Cholesterol lowering with statin drugs, risk of stroke, and total mortality [J]. JAMA, 1997,278(1):313-321.
-
4Bucher HC, Gfiffith LE, Guyatt GH. Effect of HMG-CoA reductase inhibitors on stroke, A meta-analysis of randomized, controlled trials[J].Ann Intern Med, 1998,128(1):89-95.
-
5Pedersen TR, Kjekshus J, Pyorala K, et al. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Studv(4S)[J] .Am J Cardlol, 1998,81(2):333-335.
-
6PlehnJF,Davis BalSacks FM, et al .For the CARE Investigators. Reduction of stroke incidence following myocardial infarction with pravastatin : the Cholesterol and Recurrent Events(CARE)Study[J]. Cireulation, 1999,99(1):216-223.
-
7Anonymous. Prevention of cardiovascular events and death with provastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.The Long-Term Inmrvention with Pravastatin in Ischsemic Disease (LIPID) Study Group[J]. N Engl J Med, 1998,339(19):1349-1357.
-
8Guijarro C, Blanco-Colio LM, Ortego M, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscles cells in culture[J]. Circ Res, 1998,83(3):490-500.
-
9Bryan RN,Wells SW,Miller TJ, et al .Infarct-like lesions in the brain:prevalence and anatomic characteristics at MR imaging of the elderly:data from the Cardiovascular Health Study[J]. Radiology,1997,202(1) : 47-54.
-
10Ebdres M,Laufs U, Huanf Z, et al. Stroke protection by 3-hydroxy-3-methylglutaryl(HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase[J]. Proc Natl Acad Sei USA, 1998, 95(12) :8880-8885.
-
1张战文,陈晖,王宝玉,邱春光.普罗布考联合瑞舒伐他汀钙对不稳定型心绞痛患者血脂代谢异常的临床效果[J].中国实用医刊,2017,44(5):4-6. 被引量：4
-
2吴云良,李晓岚,程红胜,杨维,姚俊龙.瑞舒伐他汀与辛伐他汀在老年冠心病患者中降脂疗效及安全性比较[J].心脑血管病防治,2011,11(3):228-230. 被引量：13
-
3王继红.辛伐他汀对高血压患者脂代谢异常的疗效观察[J].中国厂矿医学,2003,16(4):281-282.
-
4李国建.葛根素注射液治疗脑动脉硬化症47例疗效观察[J].现代预防医学,2011,38(13):2648-2649. 被引量：3
-
5王平.阿托伐他汀钙对短暂性脑缺血发作患者颈动脉粥样硬化斑块的临床观察[J].中国实用神经疾病杂志,2009,12(15):54-55. 被引量：12
-
6田东,文世昌,杨俊峰.奥扎格雷钠治疗脑梗死疗效观察[J].吉林医学,2003,24(1):79-79.
-
7王秀红,李玉龄,万雨明.盐酸丁咯地尔治疗老年糖尿病周围神经病44例临床观察[J].医学理论与实践,2003,16(1):10-11. 被引量：1
-
8王小娟,李军涛,张鹏宇.奥扎格雷钠、低分子肝素联合治疗急性脑梗死[J].实用心脑肺血管病杂志,2007,15(6):447-449.
-
9马英.脑血管病治疗中调脂药物的运用[J].检验医学与临床,2015,12(5):671-671. 被引量：1
-
10张梅兰,孟笑梅.奥扎格雷钠的临床应用[J].河北医药,2007,29(6):622-623. 被引量：13
